<DOC>
	<DOCNO>NCT02108574</DOCNO>
	<brief_summary>This study evaluate effect RHINIX™ nasal filter seasonal allergic rhinitis ( hay fever ) park setting .</brief_summary>
	<brief_title>Efficacy Park Study Assessing Rhinix™ Nasal Filters Hay Fever</brief_title>
	<detailed_description>The study include 100 participant grass allergy look efficacy usability RHINIX™ nasal filter hay fever randomize , double-blind , placebo-controlled , crossover design .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>History seasonal allergic rhinitis ( SAR ) minimum 2 year study entry . Documented positive skin test ( wheal &gt; 3mm ) within 12 month study enrolment . Written informed consent Must able complete study Reliable anticonception fertile woman FEV1 high 70 % predict value Positive grass IgE blood sample high equal 0,7 kU/L Improper fit Rhinix™ device Nasal septal deviation Retrospective TNSS last summer &lt; 3 Positive pregnancy test fertile woman Inadequate washout period regard park study appointment ( intranasal systemic corticosteroid ( 1month ) , intranasal cromolyn ( 2 week ) , intranasal systemic decongestant ( 3 day ) , intranasal systemic antihistamine ( 3 day ) , Loratadine ( 10 day ) ) . Rhinitis medicamentosa Use long act antihistamine . Documented evidence acute cronic sinusitis , determine individual investigator . FEV1 low 70 % predict value Subjects nasal condition likely affect outcome study opinion investigator , i.e . anterior nasal septum deviation , nasal septal perforation , nasal polyp , chronic nasal obstruction nasal disease . Receipt immunotherapy grass pollen within previous 10 year ( least two round treatment ) . Women breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>